Eagle Pharmaceuticals Inc (NASDAQ:EGRX)

41.48
Delayed Data
As of Apr 09
 +0.28 / +0.68%
Today’s Change
36.48
Today|||52-Week Range
56.16
-10.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues66.2M189.5M236.7M213.3M
 
 
 
 
 
Cost of Goods Sold15.5M53.7M53.4M58.2M
 
 
 
 
 
Depreciation And Amortization112.0K1.6M3.7M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income50.6M134.2M179.5M151.4M
 
 
 
 
 
General Expenses48.0M81.7M103.7M104.9M
 
 
 
 
 
Research And Development27.9M30.3M32.6M44.4M
 
 
 
 
 
Total Operating Expenses63.7M137.0M160.9M166.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.6M52.5M75.8M46.5M
 
 
 
 
 
Extraordinary Credit0.000.007.4M763.0K
 
 
 
Extraordinary Charge0.00-856.0K-9.2M-10.6M
 
 
 
 
Interest Expense On Debt11.0K0.001.1M2.7M
 
 
 
 
Other Expenses0.001.7M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.6M53.4M72.9M34.0M
 
 
 
 
 
Income Taxes-3.0K-28.0M-21.0M-2.1M
 
 
 
 
 
Net Income2.6M81.5M51.9M31.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.3M15.5M15.1M14.8M
 
 
 
 
 
Shares To Calculate EPS Diluted16.3M16.4M15.9M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.16$4.96$3.27$2.09
 
 
 
 
 
EPS Diluted$0.16$4.96$3.27$2.09